Insulet Corporation, a global leader in tubeless insulin pump technology and the maker of Omnipod products, announced its participation at CES 2026, where it will highlight its vision for “liveable technology” through an interactive booth, expert panels, and media demonstrations. The concept of liveable technology reflects Insulet’s approach to connected health, focusing on systems that are intuitive, adaptive, and designed to integrate seamlessly into daily life. As digital health solutions advance, people managing chronic conditions increasingly seek tools that reduce mental effort and provide insights only when needed. At CES, Insulet will demonstrate how its Omnipod systems embody this philosophy by simplifying diabetes management and offering automation that supports users naturally.
Health Technology Insights: Hyperfine Announces Regulatory Approval of the Swoop System in India
Manoj Raghunandanan, Chief Growth Officer at Insulet, explained that managing diabetes involves making dozens of decisions every day, which can be mentally exhausting. He emphasized that Omnipod represents technology designed to reduce this burden by fitting effortlessly into a person’s routine. According to Raghunandanan, Insulet aims to bring real change to connected health by combining medical technology, healthcare expertise, and consumer-friendly design, showing that innovation is most meaningful when it improves everyday life.
During CES 2026, Insulet will highlight Omnipod 5, its tubeless automated insulin delivery system, which integrates with a continuous glucose monitor to provide personalized insulin dosing. Omnipod 5 works in the background, helping users maintain safe blood glucose levels while minimizing the time and cognitive effort required to manage diabetes. The system exemplifies Insulet’s commitment to human-centered, calm, and intelligent technology.
Health Technology Insights: Rona Launches First Bi-valent PCSK9-LPA siRNA for Heart Risk
Insulet’s CES presence will feature a panel discussion titled “The Rise of Liveable Tech: Calm, Intelligent, and Human-First,” bringing together innovators, clinicians, and real-world users to explore how connected health is evolving to support people with chronic conditions in a more emotionally supportive and insight-driven way. The panel will be held on January 6 from 3:25 PM to 4:05 PM PT at the Venetian, Level 4, Marcello 4404.
The interactive booth at the Venetian Expo, Level 2, Booth #54412, will allow visitors to experience firsthand how liveable technology works. Attendees can explore Omnipod’s automation and design, speak with product specialists, hear stories from people living with diabetes, and preview upcoming innovations that aim to make connected health simple, empowering, and more accessible.
Omnipod 5 is designed to help users spend less time managing diabetes and more time living their lives by providing automated insulin delivery without tubing, fingersticks, or multiple daily injections. The system demonstrates Insulet’s ongoing commitment to combining consumer experience, advanced technology, and healthcare to create solutions that are both effective and human-centered.
This CES showcase underscores Insulet’s mission to make connected health more intuitive, adaptive, and supportive, reflecting the company’s broader vision for a future where technology truly enhances daily life for people managing chronic conditions.
Health Technology Insights: Wealth Enhancement to Acquire Wealth Advocates with $476 Million AUM
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
